Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. IINN
stocks logo

IINN

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Valuation Metrics

The current forward P/E ratio for Inspira Technologies Oxy BHN Ltd (IINN.O) is -7.16, compared to its 5-year average forward P/E of -2.20. For a more detailed relative valuation and DCF analysis to assess Inspira Technologies Oxy BHN Ltd 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-2.20
Current PE
-7.16
Overvalued PE
-0.62
Undervalued PE
-3.78

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-1.77
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
2.27
Undervalued EV/EBITDA
-5.81

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
10.37
Current PS
0.00
Overvalued PS
38.51
Undervalued PS
-17.76
AI Stock Picker
AI Stock Picker

Financials

Annual
Quarterly
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Gross Profit Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Financial AI Agent
Financial AI Agent

IINN News & Events

Events Timeline

(ET)
2025-12-03
08:50:00
Inspira Technologies Expands Core Blood Laboratory Capabilities
select
2025-11-13 (ET)
2025-11-13
09:06:28
Inspira Technologies Finalizes Clinical Trial for HYLA Blood Sensor
select
2025-11-06 (ET)
2025-11-06
09:13:25
Inspira Finalizes Regulatory Filing for INSPIRA ART100 in the UAE
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
7.5
10-22Newsfilter
Inspira and Bites Join Forces to Integrate AI as a Fundamental Standard Throughout Inspira's Global Network

  • Strategic Collaboration: Inspira Technologies has partnered with Bites Learning Ltd. to integrate AI-driven training and support solutions into its medical devices, enhancing operational performance and user onboarding.

  • AI-Powered Training Modules: The collaboration will deploy adaptive training modules and personalized knowledge feeds, improving proficiency and compliance for medical teams using Inspira's products.

  • Data-Driven Insights: The integrated platform will provide analytics on training efficiency and adoption rates, supporting continuous improvement and quality assurance in Inspira's operations.

  • Long-Term Growth Potential: The partnership includes options for future strategic transactions, emphasizing a shared vision for innovation and growth in the medical technology sector.

[object Object]
Preview
5.0
10-22Newsfilter
Inspira Names Ex-Johnson & Johnson Senior Business Manager as VP of Global Sales and New Board Member from Prominent International Investment Firm

  • Leadership Appointments: Inspira Technologies has appointed Mr. Mike Hershkovitz as Vice President of Global Sales and Ms. Sivan Matza as an independent director on its board, enhancing its global commercialization and governance.

  • Expertise and Experience: Ms. Matza brings extensive experience in global finance and regulation, while Mr. Hershkovitz has nearly two decades of leadership in healthcare markets, including roles at Johnson & Johnson.

  • Strategic Growth: The new appointments are seen as a strategic move to bolster Inspira's capabilities and accelerate the adoption of its medical technologies in hospitals worldwide.

  • Company Overview: Inspira Technologies specializes in advanced respiratory support and blood monitoring solutions, with FDA-cleared products and a focus on innovation in the MedTech landscape.

[object Object]
Preview
5.0
10-21Newsfilter
Inspira Hires Ex-Johnson & Johnson Executive as Global Sales VP and Welcomes New Board Member from Prominent International Investment Firm

  • Leadership Appointments: Inspira Technologies has appointed Mr. Mike Hershkovitz as Vice President of Global Sales and Ms. Sivan Matza as an independent director on its board, enhancing its global commercialization and governance.

  • Expertise and Experience: Ms. Matza brings extensive experience in global finance and regulation, while Mr. Hershkovitz has nearly two decades of leadership in healthcare markets, including roles at Johnson & Johnson.

  • Strategic Growth: The new appointments are seen as a strategic move to bolster Inspira's capabilities and accelerate the adoption of its medical technologies in hospitals worldwide.

  • Company Overview: Inspira Technologies specializes in advanced respiratory support and blood monitoring solutions, with FDA-cleared products and a focus on innovation in the MedTech landscape.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Inspira Technologies Oxy BHN Ltd (IINN) stock price today?

The current price of IINN is 1.11 USD — it has increased 3.74 % in the last trading day.

arrow icon

What is Inspira Technologies Oxy BHN Ltd (IINN)'s business?

Inspira Technologies Oxy B.H.N Ltd, formerly Insense Medical Ltd, incorporated on February 27, 2018, is a specialty medical device company based in Israel. The Company is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). It provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV.

arrow icon

What is the price predicton of IINN Stock?

Wall Street analysts forecast IINN stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for IINN is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Inspira Technologies Oxy BHN Ltd (IINN)'s revenue for the last quarter?

Inspira Technologies Oxy BHN Ltd revenue for the last quarter amounts to -3.16M USD, decreased -3.78 % YoY.

arrow icon

What is Inspira Technologies Oxy BHN Ltd (IINN)'s earnings per share (EPS) for the last quarter?

Inspira Technologies Oxy BHN Ltd. EPS for the last quarter amounts to 0.69 USD, decreased % YoY.

arrow icon

What changes have occurred in the market's expectations for Inspira Technologies Oxy BHN Ltd (IINN)'s fundamentals?

The market is revising No Change the revenue expectations for Inspira Technologies Oxy B.H.N. Ltd. (IINN) for FY2025, with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -8.26%.
arrow icon

How many employees does Inspira Technologies Oxy BHN Ltd (IINN). have?

Inspira Technologies Oxy BHN Ltd (IINN) has 38 emplpoyees as of December 05 2025.

arrow icon

What is Inspira Technologies Oxy BHN Ltd (IINN) market cap?

Today IINN has the market capitalization of 36.28M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free